Role of endogenous hydrogen sulfide in the control of vascular aging
Description: Human aging and age-associated diseases represent one of the biggest health challenges faced by developed and developing countries. As the body ages, one of the most dramatic and threatening changes is the decline in the function of endothelial cells that line the vasculature. Clinical manifestations of endothelial senescence include hypertension, myocardial infarction, stroke, dementia, critical limb ischemia, impaired wound healing, muscle decline, and exercise intolerance. Importantly, vascular dysfunction in the elderly is one of the strongest predictors of imminent death. This suggests that a better mechanistic understanding underlying vascular aging, and novel strategies to intervene in this process could tremendously impact lifespan, and the quality of life in this growing population of aged (>65 years old) individuals. Dietary Restriction (DR), defined as reduced food intake without malnutrition, was first described nearly a century ago by McCay and colleagues to extend lifespan in rats. Since then, it has been shown in a multitude of organisms that DR increases lifespan and confers protection against age-associated diseases such as hypertension and ischemia of the limbs, heart, or brain. Unfortunately, DR is practically impossible to achieve in humans. Thus, extensive efforts have been dedicated to the identification of the nutritional, cellular and molecular mechanisms that underlie DR benefits. We recently reported that DR increases endogenous hydrogen sulfide (H2S) production in endothelial cells via specific upregulation of the enzyme cystathionine ?-lyase (CGL). In this context, the increase in CGL/H2S was necessary and sufficient to increase muscle capillary density and improve recovery from ischemic injury upon femoral artery ligation. Of interest, circulating levels of H2S decline dramatically with age-associated pathologies. However, the role of CGL/H2S in vascular homeostasis with advancing age, or the relevant cellular source of H2S in this context, are unknown. We propose that H2S represent a new endothelial-derived circulating anti-aging molecule, which holds therapeutic promise to restore more youthful function to aging tissues. In this project, we will use DR as well as transgenic models to stimulate endogenous H2S production from endothelial cells. We will define H2S therapeutic relevance in the prevention and treatment of age-related disease, especially skeletal muscle dysfunction and hypertension, central elements of the vascular aging process, according to the following specific aims: Aim 1. Evaluate the role of H2S in preventing endothelial cell senescence.Aim 2. Clarify the basis for the age-and ischemia-dependent effects on muscle function.Aim 3. Establish the impact of aging on circulating H2S levels in human.Together, these studies will lend important insights into the basic science of vascular aging, especially endothelial cell dysfunction, as well as open new avenues for the rapid development of therapeutics of age-related diseases, such as skeletal muscle dysfunction and hypertension.
Amount: CHF 894,100
Funding type: fellowship
Funder scheme: Ambizione
Start date: 2020-07-01
End date: 2024-08-31
Investigator: Longchamp, Alban (lead)
Institutions: University of Lausanne, University of Lausanne – LA
Topic: Sulfur Compounds in Biology
Subfield: Biochemistry
Domain: Life Sciences
Funded outputs count: 30
Funder award ID: 185927
OpenAlex ID: G8181044754
